COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City

被引:1
|
作者
Khezri, Mehrdad [1 ,2 ,3 ]
McKnight, Courtney [1 ,4 ]
Weng, Chenziheng Allen [1 ]
Kimball, Sarah [1 ]
Des Jarlais, Don [1 ,4 ]
机构
[1] NYU, Sch Global Publ Hlth, Dept Epidemiol, New York, NY 10012 USA
[2] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran
[3] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran
[4] Ctr Drug Use & HIV HCV Res, New York, NY USA
来源
PLOS ONE | 2024年 / 19卷 / 05期
关键词
UNITED-STATES;
D O I
10.1371/journal.pone.0303394
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Persons who inject drugs (PWID) may be unengaged with healthcare services and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to chronic diseases and structural inequities. However, data on COVID-19 vaccine uptake, particularly booster vaccination, among PWID are limited. We examined COVID-19 vaccine uptake and factors associated with booster vaccination among PWID in New York City (NYC).Methods We recruited PWID using respondent-driven sampling from October 2021 to November 2023 in a survey that included HIV and SARS-CoV-2 antibodies testing. The questionnaire included demographics, COVID-19 vaccination and attitudes, and drug use behaviors.Results Of 436 PWID, 80% received at least one COVID-19 vaccine dose. Among individuals who received at least one COVID-19 vaccine dose, 95% were fully vaccinated. After excluding participants recruited before booster authorization for general adults started in NYC, and those who had never received an initial vaccination, 41% reported having received a COVID-19 booster vaccine dose. COVID-19 booster vaccination was significantly associated with having a high school diploma or GED (adjusted odds ratio (aOR) 1.93; 95% confidence interval (CI) 1.09, 3.48), ever received the hepatitis A/B vaccine (aOR 2.23; 95% CI 1.27, 3.96), main drug use other than heroin/speedball, fentanyl and stimulants (aOR 14.4; 95% CI 2.32, 280), number of non-fatal overdoses (aOR 0.35; 95% CI 0.16, 0.70), and mean vaccination attitude score (aOR 0.94; 95% CI 0.89, 0.98).Conclusions We found a suboptimal level of COVID-19 booster vaccination among PWID, which was consistent with the rates observed in the general population in NYC and the U.S. Community-based interventions are needed to improve COVID-19 booster vaccination access and uptake among PWID. Attitudes towards vaccination were significant predictors of both primary and booster vaccination uptake. Outreach efforts focusing on improving attitudes towards vaccination and educational programs are essential for reducing hesitancy and increasing booster vaccination uptake among PWID.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] COVID-19 vaccine deliberation among people who inject drugs
    Cioffi, Camille C.
    Kosty, Derek
    Nachbar, Sarah
    Capron, Christopher G.
    Mauricio, Anne Marie
    Tavalire, Hannah F.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2022, 3
  • [42] Hepatitis A and B among young persons who inject drugs-Vaccination, past, and present infection
    Collier, Melissa G.
    Drobeniuc, Jan
    Cuevas-Mota, Jazmine
    Garfein, Richard S.
    Kamili, Saleem
    Teshale, Eyasu H.
    VACCINE, 2015, 33 (24) : 2808 - 2812
  • [43] Response: COVID-19 vaccination uptake among pregnant individuals
    Rodriguez-Sibaja, Maria J.
    Acevedo-Gallegos, Sandra
    Lumbreras-Marquez, Mario I.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 159 (02) : 611 - 611
  • [44] COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
    Lu, Peng-jun
    Srivastav, Anup
    Vashist, Kushagra
    Black, Carla L.
    Kriss, Jennifer L.
    Hung, Mei-Chuan
    Meng, Lu
    Zhou, Tianyi
    Yankey, David
    Masters, Nina B.
    Fast, Hannah E.
    Razzaghi, Hilda
    Singleton, James A.
    EMERGING INFECTIOUS DISEASES, 2023, 29 (01) : 133 - 140
  • [45] Reaction after COVID-19 mRNA booster vaccination
    Degala, Ami
    Degala, Anjali
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 567 - 567
  • [46] COVID-19 booster vaccination in rural community pharmacies
    Gamble, Abigail
    Hastings, Tessa J.
    Westrick, Salisa C.
    Smith, Megan
    Hannings, Ashley N.
    Robinson, Jessica M.
    Rosenthal, Meagen
    Kiser, Stephanie N.
    Curran, Geoffrey
    Carpenter, Delesha M.
    VACCINE, 2023, 41 (05) : 999 - 1002
  • [47] Strategies and safety considerations of booster vaccination in COVID-19
    Meng, Hanyan
    Mao, Jianhua
    Ye, Qing
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (03) : 366 - 373
  • [48] Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
    Vukcevic, Marija
    Despot, Mateja
    Nikolic-Kokic, Aleksandra
    Blagojevic, Dusko
    Nikolic, Milan
    Banko, Ana
    Jovanovic, Tanja
    Despot, Dragana
    PHARMACEUTICALS, 2024, 17 (12)
  • [49] Covid-19: Booster vaccination reduces hospitalizations for IBD
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (09):
  • [50] Comparison of Current Attitudes Toward COVID-19 Vaccination in New York City and the US Nationally
    El-Mohandes, Ayman
    Wyka, Katarzyna
    White, Trenton M.
    El-Sadr, Wafaa M.
    Rauh, Lauren
    Vasan, Ashwin
    Greene, Danielle
    Rabin, Kenneth
    Ratzan, Scott C.
    Chaudhri, Simran
    Kimball, Spencer
    Lazarus, Jeffrey, V
    JOURNAL OF HEALTH COMMUNICATION, 2023, 28 : 34 - 44